FMO5 and psoriasis: Significantly higher circulating neutrophils (<i>p</i> < 0.001) and levels of NET-associated markers (i.e., MPO-DNA complex, CitH3, PAD4, NADPH oxidase, and NE) were observed in active psoriasis patients compared to controls.